Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fleischhauer

Showing results (461-470 of 529) with videos related to

Pageof 53
Sort By:
Haematologica|December 5, 2024
Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell TherapyWolfgang Bethge, Sarah Flossdorf, Franziska Hanke, et al.
Leukemia|May 16, 2020
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemiaFrancesca Lorentino, Myriam Labopin, Fabio Ciceri, et al.
Leukemia|May 2, 2008
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donorsB Mazzi, T D Clerici, M Zanussi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 10, 2013
Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide geneMonica Casucci, Serena Kimi Perna, Laura Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor TransplantationEffie W Petersdorf, Mats Bengtsson, Dianne De Santis, et al.
Blood|November 4, 2008
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytesShin Kaneko, Sara Mastaglio, Attilio Bondanza, et al.
Blood|June 12, 2009
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantationRoberto Crocchiolo, Elisabetta Zino, Luca Vago, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2020
Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional HierarchiesPeter van Balen, Michel G D Kester, Wendy de Klerk, et al.
The Lancet. Oncology|February 21, 2012
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective studyKatharina Fleischhauer, Bronwen E Shaw, Theodore Gooley, et al.
Cancer Immunity|May 20, 2004
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFADanielle Liénard, Donata Rimoldi, Marie Marchand, et al.
Pageof 53

Showing results (461-470 of 529) with videos related to

Sort By:
Pageof 53
Haematologica|December 5, 2024
Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell TherapyWolfgang Bethge, Sarah Flossdorf, Franziska Hanke, et al.
Leukemia|May 16, 2020
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemiaFrancesca Lorentino, Myriam Labopin, Fabio Ciceri, et al.
Leukemia|May 2, 2008
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donorsB Mazzi, T D Clerici, M Zanussi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 10, 2013
Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide geneMonica Casucci, Serena Kimi Perna, Laura Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor TransplantationEffie W Petersdorf, Mats Bengtsson, Dianne De Santis, et al.
Blood|November 4, 2008
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytesShin Kaneko, Sara Mastaglio, Attilio Bondanza, et al.
Blood|June 12, 2009
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantationRoberto Crocchiolo, Elisabetta Zino, Luca Vago, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2020
Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional HierarchiesPeter van Balen, Michel G D Kester, Wendy de Klerk, et al.
The Lancet. Oncology|February 21, 2012
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective studyKatharina Fleischhauer, Bronwen E Shaw, Theodore Gooley, et al.
Cancer Immunity|May 20, 2004
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFADanielle Liénard, Donata Rimoldi, Marie Marchand, et al.
Pageof 53